Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Richard W. Troughton

2 Riccarton Avenue, 
Christchurch, CAN, NZ 
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)
2 Riccarton Avenue, 
Christchurch, CAN, NZ 
OverviewLocationsClinical Research

Overview

Richard Troughton practices in Christchurch, New Zealand. Mr. Troughton is rated as an Advanced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

His clinical research consists of co-authoring 196 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

2 Riccarton Avenue, Christchurch, CAN 8011, New Zealand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2025
Intervention Type: Other, Device
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure
The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure
Enrollment Status: Completed
Publish Date: January 31, 2023
Intervention Type: Other
Study Phase: Phase 3
View 2 Less Clinical Trials

196 Total Publications

The Asia Pacific Cardiovascular Research (ASPIRE) Network: Facilitating and Advancing Regional Cardiovascular Clinical Trials.
The Asia Pacific Cardiovascular Research (ASPIRE) Network: Facilitating and Advancing Regional Cardiovascular Clinical Trials.
Journal: JACC. Asia
Published: May 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Troughton's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile